Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS

Clinical trial NCT01757015 · WITHDRAWN

Trial details

NCT number: NCT01757015
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2013-04-01
Primary completion: 2014-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.